Ep 147: Joe Fahmy: Selling Rules Critical For Portfolio Gains
Investing With IBD
00:00
Micron's Estimates Slowing Down
Some of the smaller cap names you have to take the estimates with a grain of salt if it's two or three analysts following it. It also depends on, you know, something like alphabet, they grew 100% last year and they're only expected to grow 5%. Sometimes there's a wide range in estimates, which tells me that the analysts really don't know what's going on. But I still want to try to stick with solid principles and make sure there's strong earnings and sales growth on the table.
Transcript
Play full episode
